Annual report pursuant to Section 13 and 15(d)

ABEONA THERAPEUTICS LLC ACQUISITION (Details)

v3.7.0.1
ABEONA THERAPEUTICS LLC ACQUISITION (Details)
 12 Months Ended
May 15, 2015
USD ($)
Milestone
$ / shares
shares
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Total purchase price [Abstract]      
Initial consideration   $ 0 $ 31,758,000
Allocation of the purchase price [Abstract]      
Goodwill   32,466,000 32,466,000
Contingent consideration liability   0 2,591,000
Abeona Therapeutics LLC [Member]      
Business Acquisition [Line Items]      
Stock issued in acquisition (in shares) | shares 3,979,761    
Business acquisition, share price (in dollars per share) | $ / shares $ 7.98    
Number of shares issued to company (in shares) | shares (3,979,761)    
Number of milestones | Milestone 3    
Total purchase price [Abstract]      
Initial consideration $ 31,758,000    
Contingent consideration 6,489,000    
Total purchase price 38,247,000    
Allocation of the purchase price [Abstract]      
Cash 3,697,000    
Accounts receivable 1,000    
Prepaid expenses 28,000    
Property and equipment 51,000    
Other assets 1,000    
Accounts payable (153,000)    
Total tangible assets 3,625,000    
Licensing agreement 2,156,000    
Goodwill 32,466,000    
Total net asset value 38,247,000    
Acquisition transaction cost $ 375,000    
Contingent consideration liability   1,391,000 $ 3,898,000
Milestone payment   $ 1,200,000